The Transplant and Cellular Therapy (TCT) Program at The University of Tennessee Medical Center offers advanced treatments for complex blood cancers and disorders. It specializes in peripheral blood stem cell transplants, CAR T-cell therapy, and clinical trials.

The multidisciplinary team, led by Dr. Kelly McCaul, provides comprehensive, individualized care, including pre- and post-transplant support. The program ensures patients have access to cutting-edge therapies close to home, enhancing their treatment experience and outcomes.